Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Discontinuation of Oral Anticoagulation After AF Catheter Ablation (ALONE-AF): ALONE, but Not the Only One
  The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes.
• ACC CardiaCast: Understanding the Spectrum: Causes and Risks of HTG and sHTG
  This episode is part of ACC’s ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG).
• Updated Global Definition of HF Aims to Improve Prevention, Diagnosis and Treatment
  The newly released AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (HF) addresses "changes in disease manifestations, diagnostic strategies and understanding of pathophysiology" and seeks to align terminology...
• ERAS-Based Signaling in Cardiology Fellowship Recruitment
  A recent JACC review explores the growing impact of Electronic Residency Application Service (ERAS)-based signaling in cardiology fellowship recruitment, highlighting the most recent data, areas of future investigation, and practical guidance for applicants and programs.
• HHS Releases Consumer Alert on Fraudulent CV Testing Schemes
  The U.S. Department of Health and Human Services' (HHS') Office of Inspector General has issued a consumer alert, urging parents, caregivers, athletic programs and student athletes to beware of fraudulent cardiovascular testing schemes exploiting fears around sudden cardiac arrest in young athletes.